Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Cannabis sector.

<< Previous

Bullboard Posts

Next >>

Comment by Lemoyneon Feb 08, 2021 3:04pm

224 Views

Post# 32503470

RE:RE:Cannabis sector.

IMO, it is outstanding for LABS to hold and consolidate near .80 level. Spiking from .80 vs .60 is a qhole other level.

Don't forget, underwriter has 18.4M reasons (max 10% ownership of 184 M outstanding shares) to keep this under a buck and rake in his 10% extra payment. At this kind of volume he can easily sell to keep this low. And selling at this level gives him 80% profit over his .44 shares.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario